Symbols / PLSE $24.43 +1.88% Pulse Biosciences, Inc.

Healthcare • Medical Instruments & Supplies • United States • NCM
PLSE Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers nPulse System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; nPulse Vybrance Percutaneous Electrode system for soft tissue ablation in surgical setting; nPulse Cardiac Surgical Clamp designed for use in surgical treatment of atrial fibrillation (AF); nPulse Cardiac Catheter System designed to provide a circumferential, or circular, ablation in a single treatment cycle; and nPulse Console, a software-enabled console-based platform designed to accommodate the clinical workflow preferred by physicians. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Miami, Florida.

Fundamentals
Scroll to Statements
Market Cap 1.66B Enterprise Value 1.56B Income -72.78M Sales 350.00K Book/sh 1.19 Cash/sh 1.19
Dividend Yield — Payout 0.00% Employees 116 IPO — P/E — Forward P/E -28.41
PEG — P/S 4745.64 P/B 20.55 P/C — EV/EBITDA -20.52 EV/Sales 4449.07
Quick Ratio 10.22 Current Ratio 10.53 Debt/Eq 9.34 LT Debt/Eq — EPS (ttm) -1.08 EPS next Y -0.86
EPS Growth — Revenue Growth — Earnings 2026-05-07 ROA -42.37% ROE -74.45% ROIC —
Gross Margin -54.00% Oper. Margin -69.14% Profit Margin 0.00% Shs Outstand 67.99M Shs Float 17.79M Short Float 16.20%
Short Ratio 11.20 Short Interest — 52W High 26.30 52W Low 12.56 Beta 1.69 Avg Volume 356.82K
Volume 185.21K Target Price $30.00 Recom Strong_buy Prev Close $23.98 Price $24.43 Change 1.88%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$30.00
Mean price target
2. Current target
$24.43
Latest analyst target
3. DCF / Fair value
$-7.81
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$24.43
Low
$30.00
High
$30.00
Mean
$30.00

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2025-07-07 init Oppenheimer — → Outperform $22
2022-09-21 down Maxim Group Buy → Hold —
2022-05-13 down HC Wainwright & Co. Buy → Neutral —
2022-04-01 main Stephens & Co. — → Overweight $12
2022-04-01 main HC Wainwright & Co. — → Buy $9
2022-02-10 main HC Wainwright & Co. — → Buy $20
2021-11-16 main HC Wainwright & Co. — → Buy $43
2021-07-27 init Stephens & Co. — → Overweight $28
2021-03-11 init Maxim Group — → Buy $40
2021-01-26 main HC Wainwright & Co. — → Buy $40
2020-05-12 up HC Wainwright & Co. Neutral → Buy $16
2020-02-14 down HC Wainwright & Co. Buy → Neutral $6
2019-02-25 init HC Wainwright & Co. — → Buy —
News
RSS: Latest PLSE news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-02-18 DANAHY KEVIN PATRICK Officer — 5,000 $23.64 $118,200
2026-02-18 DANAHY KEVIN PATRICK Officer — 5,000 $1.53 $7,650
2026-02-17 DANAHY KEVIN PATRICK Officer — 60,000 $23.37 $1,410,600
2026-02-17 DANAHY KEVIN PATRICK Officer — 60,000 $1.53 $91,800
2026-02-11 DANAHY KEVIN PATRICK Officer — 60,000 $21.45 $1,403,400
2026-02-11 DANAHY KEVIN PATRICK Officer — 60,000 $1.53 $91,800
2025-10-02 DANAHY KEVIN PATRICK Officer — 4,600 $18.53 $85,238
2025-10-02 DANAHY KEVIN PATRICK Officer — 4,600 $1.53 $7,038
2025-09-19 DANAHY KEVIN PATRICK Officer — 20,400 $18.48 $377,192
2025-09-19 DANAHY KEVIN PATRICK Officer — 20,400 $1.53 $31,212
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.35
0.00
0.00
-100.00%
0.70
Operating Revenue
0.35
0.00
0.00
-100.00%
0.70
Cost Of Revenue
0.54
0.00
0.00
-100.00%
11.94
Reconciled Cost Of Revenue
0.54
0.00
0.00
-100.00%
11.94
Gross Profit
-0.19
0.00
0.00
+100.00%
-11.24
Operating Expense
76.75
+36.43%
56.26
+29.11%
43.57
-6.92%
46.81
Research And Development
44.72
+38.30%
32.34
+16.33%
27.80
+33.39%
20.84
Selling General And Administration
32.03
+33.89%
23.92
+51.62%
15.78
-39.26%
25.97
Selling And Marketing Expense
—
—
0.00
-100.00%
12.02
General And Administrative Expense
—
23.92
+51.62%
15.78
+13.06%
13.96
Other Gand A
—
23.92
+51.62%
15.78
+13.06%
13.96
Total Expenses
77.29
+37.39%
56.26
+29.11%
43.57
-25.84%
58.76
Operating Income
-76.94
-36.76%
-56.26
-29.11%
-43.57
+24.95%
-58.06
Total Operating Income As Reported
-76.94
-36.76%
-56.26
-29.11%
-43.57
+24.95%
-58.06
EBITDA
-75.87
-37.74%
-55.08
-30.00%
-42.37
+25.28%
-56.70
Normalized EBITDA
-75.87
-37.74%
-55.08
-30.00%
-42.37
+25.28%
-56.70
Reconciled Depreciation
1.07
-9.08%
1.18
-2.40%
1.21
-10.92%
1.35
EBIT
-76.94
-36.76%
-56.26
-29.11%
-43.57
+24.95%
-58.06
Net Income
-72.78
-35.82%
-53.59
-26.95%
-42.21
+27.85%
-58.51
Pretax Income
-72.78
-35.82%
-53.59
-26.95%
-42.21
+27.85%
-58.51
Net Non Operating Interest Income Expense
4.21
+56.51%
2.69
+97.21%
1.36
+404.46%
-0.45
Net Interest Income
4.21
+56.51%
2.69
+97.21%
1.36
+404.46%
-0.45
Interest Income Non Operating
4.21
+56.51%
2.69
—
—
Interest Income
4.21
+56.51%
2.69
—
—
Other Income Expense
-0.05
-188.89%
-0.02
—
—
Other Non Operating Income Expenses
-0.05
-188.89%
-0.02
—
—
Tax Provision
—
0.00
0.00
0.00
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-72.78
-35.82%
-53.59
-26.95%
-42.21
+27.85%
-58.51
Net Income From Continuing Operation Net Minority Interest
-72.78
-35.82%
-53.59
-26.95%
-42.21
+27.85%
-58.51
Net Income From Continuing And Discontinued Operation
-72.78
-35.82%
-53.59
-26.95%
-42.21
+27.85%
-58.51
Net Income Continuous Operations
-72.78
-35.82%
-53.59
-26.95%
-42.21
+27.85%
-58.51
Normalized Income
-72.78
-35.82%
-53.59
-26.95%
-42.21
+27.85%
-58.51
Net Income Common Stockholders
-72.78
-35.82%
-53.59
-26.95%
-42.21
+27.85%
-58.51
Diluted EPS
—
-0.92
-8.24%
-0.85
+49.74%
-1.69
Basic EPS
—
-0.92
-8.24%
-0.85
+49.74%
-1.69
Basic Average Shares
—
58.40
+17.41%
49.74
+44.12%
34.51
Diluted Average Shares
—
58.40
+17.41%
49.74
+44.12%
34.51
Diluted NI Availto Com Stockholders
-72.78
-35.82%
-53.59
-26.95%
-42.21
+27.85%
-58.51
Total Other Finance Cost
—
-2.67
-95.89%
-1.36
-404.46%
0.45
Line Item Trend 2023-12-31
Total Assets
59.15
Current Assets
45.33
Cash Cash Equivalents And Short Term Investments
44.37
Cash And Cash Equivalents
44.37
Other Short Term Investments
—
Receivables
—
Accounts Receivable
—
Inventory
—
Raw Materials
—
Work In Process
—
Finished Goods
—
Prepaid Assets
—
Other Current Assets
0.96
Total Non Current Assets
13.83
Net PPE
8.78
Gross PPE
12.26
Accumulated Depreciation
-3.48
Properties
0.00
Machinery Furniture Equipment
1.24
Construction In Progress
0.00
Other Properties
8.50
Leases
2.52
Goodwill And Other Intangible Assets
4.68
Goodwill
2.79
Other Intangible Assets
1.89
Other Non Current Assets
0.36
Total Liabilities Net Minority Interest
14.79
Current Liabilities
6.71
Payables And Accrued Expenses
2.45
Payables
1.84
Accounts Payable
1.84
Current Accrued Expenses
0.61
Pensionand Other Post Retirement Benefit Plans Current
3.20
Current Debt And Capital Lease Obligation
1.06
Current Debt
—
Other Current Borrowings
—
Current Capital Lease Obligation
1.06
Current Deferred Liabilities
—
Current Deferred Revenue
—
Total Non Current Liabilities Net Minority Interest
8.09
Long Term Debt And Capital Lease Obligation
8.09
Long Term Debt
—
Long Term Capital Lease Obligation
8.09
Stockholders Equity
44.36
Common Stock Equity
44.36
Capital Stock
0.06
Common Stock
0.06
Preferred Stock
0.00
Share Issued
56.08
Ordinary Shares Number
56.08
Treasury Shares Number
0.00
Additional Paid In Capital
381.22
Retained Earnings
-336.92
Gains Losses Not Affecting Retained Earnings
0.00
Total Equity Gross Minority Interest
44.36
Total Capitalization
44.36
Working Capital
38.62
Invested Capital
44.36
Total Debt
9.14
Net Debt
—
Capital Lease Obligations
9.14
Net Tangible Assets
39.68
Tangible Book Value
39.68
Current Notes Payable
—
Current Provisions
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-54.12
-48.92%
-36.34
-9.99%
-33.04
+29.72%
-47.01
Cash Flow From Continuing Operating Activities
-54.12
-48.92%
-36.34
-9.99%
-33.04
+29.72%
-47.01
Net Income From Continuing Operations
-72.78
-35.82%
-53.59
-26.95%
-42.21
+27.85%
-58.51
Depreciation Amortization Depletion
1.07
-9.08%
1.18
-2.40%
1.21
-10.92%
1.35
Depreciation
0.41
-20.70%
0.51
-5.54%
0.54
-21.45%
0.69
Amortization Cash Flow
0.67
-0.15%
0.67
+0.15%
0.67
+0.00%
0.67
Depreciation And Amortization
1.07
-9.08%
1.18
-2.40%
1.21
-10.92%
1.35
Amortization Of Intangibles
0.67
-0.15%
0.67
+0.15%
0.67
+0.00%
0.67
Other Non Cash Items
1.15
+24.92%
0.92
—
—
Stock Based Compensation
21.46
+57.93%
13.59
+89.19%
7.18
+38.34%
5.19
Asset Impairment Charge
—
—
0.00
-100.00%
8.48
Operating Gains Losses
—
0.01
-53.85%
0.01
-92.97%
0.18
Gain Loss On Sale Of PPE
0.00
-100.00%
0.01
-53.85%
0.01
-92.97%
0.18
Change In Working Capital
-5.02
-424.21%
1.55
+101.69%
0.77
+120.67%
-3.72
Change In Receivables
-0.27
0.00
-100.00%
0.11
+445.00%
0.02
Changes In Account Receivables
-0.27
0.00
0.00
-100.00%
0.06
Change In Inventory
-0.14
0.00
0.00
+100.00%
-2.65
Change In Prepaid Assets
-0.91
-156.90%
-0.35
-446.15%
-0.07
-105.58%
1.16
Change In Payables And Accrued Expense
-2.32
-176.98%
3.01
+269.90%
0.81
+137.34%
-2.18
Change In Accrued Expense
-3.45
-207.41%
3.21
+482.94%
0.55
+162.90%
-0.88
Change In Payable
1.13
+663.18%
-0.20
-176.43%
0.26
+120.17%
-1.30
Change In Account Payable
1.13
+663.18%
-0.20
-176.43%
0.26
+120.17%
-1.30
Change In Other Working Capital
—
—
—
-0.02
Change In Other Current Assets
-0.01
+54.84%
-0.03
-103.85%
0.81
+11.48%
0.72
Change In Other Current Liabilities
-1.37
-27.14%
-1.08
-20.09%
-0.90
-15.76%
-0.77
Investing Cash Flow
-0.34
-168.00%
-0.12
-3.31%
-0.12
+69.83%
-0.40
Cash Flow From Continuing Investing Activities
-0.34
-168.00%
-0.12
-3.31%
-0.12
+69.83%
-0.40
Net PPE Purchase And Sale
-0.32
-152.00%
-0.12
-3.31%
-0.12
+69.83%
-0.40
Purchase Of PPE
-0.32
-152.00%
-0.12
-3.31%
-0.12
+69.83%
-0.40
Capital Expenditure
-0.34
-168.00%
-0.12
-3.31%
-0.12
+69.83%
-0.40
Net Investment Purchase And Sale
—
—
—
0.00
Purchase Of Investment
—
—
—
0.00
Sale Of Investment
—
—
—
0.00
Net Intangibles Purchase And Sale
-0.02
0.00
—
—
Purchase Of Intangibles
-0.02
0.00
—
—
Financing Cash Flow
17.15
-84.43%
110.14
+572.08%
16.39
-79.50%
79.94
Cash Flow From Continuing Financing Activities
17.15
-84.43%
110.14
+572.08%
16.39
-79.50%
79.94
Net Issuance Payments Of Debt
—
—
0.00
-100.00%
65.00
Issuance Of Debt
—
—
0.00
-100.00%
65.00
Repayment Of Debt
—
—
—
-0.44
Long Term Debt Issuance
—
—
0.00
-100.00%
65.00
Long Term Debt Payments
—
—
—
—
Net Long Term Debt Issuance
—
—
0.00
-100.00%
65.00
Short Term Debt Issuance
—
—
—
65.00
Short Term Debt Payments
—
—
—
-0.44
Net Short Term Debt Issuance
—
—
—
64.56
Net Common Stock Issuance
0.00
-100.00%
59.65
0.00
-100.00%
14.86
Proceeds From Stock Option Exercised
17.15
-66.21%
50.77
+209.70%
16.39
+3101.95%
0.51
Net Other Financing Charges
—
-0.28
-4583.33%
-0.01
+98.63%
-0.44
Changes In Cash
-37.30
-150.63%
73.67
+539.21%
-16.77
-151.57%
32.52
Beginning Cash Position
118.04
+166.06%
44.37
-27.44%
61.14
+113.67%
28.61
End Cash Position
80.73
-31.60%
118.04
+166.06%
44.37
-27.44%
61.14
Free Cash Flow
-54.46
-49.33%
-36.47
-9.97%
-33.16
+30.06%
-47.41
Amortization Of Securities
—
—
—
0.00
Change In Interest Payable
—
0.00
+100.00%
-0.67
-172.77%
0.92
Common Stock Issuance
0.00
-100.00%
59.65
0.00
-100.00%
14.86
Issuance Of Capital Stock
0.00
-100.00%
59.65
0.00
-100.00%
14.86
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category